BioSpace News Archive

Fox Trail Memory Care Living, a specialized Alzheimer’s and dementia subsidiary of Fox Trail Senior Living, has launched a pioneer “Living Life Well” program. T

Healthcare has never been easy. We all need it, but picking and choosing what plans to go with, the right doctor to see and making sure the selected facility is in network can be overwhelming.

NeurologyLive™, a digital and print media enterprise platform dedicated to providing health care professionals treating neurological diseases direct access to expert practice-changing news and insights in neurology, presents its most recent Peer Exchange panel discussion titled “Chronic Migraine: New Paradigms in Management.

National Partners in Healthcare (NPH), a national healthcare organization delivering best in class anesthesiology services, announced today that National Medical Billing Management (NMBM) has partnered with NPH.

Ayasdi, a pioneer in the creation and deployment of enterprise-class intelligent applications for the healthcare industry, announced today that it was named the Accenture HealthTech Innovation Challenge Innovation Champion.

A recent study showed enhanced bioavailability of the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) administered in a proprietary self-micro-emulsifying delivery system (SMEDS) formulation compared to a standard ethyl ester delivery.

Flora California Prime Inc. (Flora), a San Diego-based cannabis company focused on the health and wellness space with existing operations throughout California and offices in Buffalo, has been approved to acquire 47 useable acres at the Buffalo Lakeside Commerce Park from the Buffalo Urban Development Corp., making it one of the largest of its kinds in the nation.

Alopexx Vaccine, LLC announced today that it has entered into an exclusive global license agreement with Merck Animal Health to develop and commercialize its poly-N-acetyl glucosamine (PNAG) vaccine for Rhodococcus equi (R. equi) pneumonia in foals, as well as other infections in the equine field

With nearly 1,300 Chinese radiation oncology professionals in attendance and an additional 8,000 users watching via a live webcast, Varian (NYSE: VAR) recently held its 2019 China Users Meeting in Wuhan, China January 12-13. T

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the Health Canada regulatory approval of QuantiFERON®-TB Gold Plus (QFT®-Plus) as an in vitro diagnostic test to detect latent tuberculosis (TB) infection.